Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
about
Novel therapeutic targets for pancreatic cancerTargeting leukemia stem cells: which pathways drive self-renewal activity in T-cell acute lymphoblastic leukemia?Molecular classification of gastric cancer: Towards a pathway-driven targeted therapyEmerging roles of PDGF-D in EMT progression during tumorigenesisThe role of cancer stem cells and miRNAs in defining the complexities of brain metastasisActivated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathwaysMethylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatinLeptin-Notch signaling axis is involved in pancreatic cancer progressionNotch1 activation is a poor prognostic factor in patients with gastric cancer.Aberrant regulation of FBW7 in cancer.Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemiaNotch3 pathway alterations in ovarian cancer.Expression of Notch Gene and Its Impact on Survival of Patients with Resectable Non-small Cell Lung Cancer.NILCO biomarkers in breast cancer from Chinese patientsTargeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase familyEndothelial Kruppel-like factor 4 regulates angiogenesis and the Notch signaling pathway.Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.Role of Notch and its oncogenic signaling crosstalk in breast cancer.Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cellsHypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells.Systematic identification of signaling pathways with potential to confer anticancer drug resistance.Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study.Investigational Notch and Hedgehog inhibitors--therapies for cardiovascular disease.Emerging roles of the FBW7 tumour suppressor in stem cell differentiation.A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors.The two faces of FBW7 in cancer drug resistance.Molecular targeted approaches for treatment of pancreatic cancer.Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer.γ-secretase inhibition combined with cisplatin enhances apoptosis of nasopharyngeal carcinoma cellsMolecular pathogenesis of mantle cell lymphoma.Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancerNicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivoNotch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer.Notch1 regulates angio-supportive bone marrow-derived cells in mice: relevance to chemoresistance.Notch Signaling Pathway in Pancreatic Cancer ProgressionNotch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes through AP-1/microRNA-451 Mediated Regulation of MDR-1.Emerging role of mucins in epithelial to mesenchymal transition.Clinical implications of APEX1 and Jagged1 as chemoresistance factors in biliary tract cancerObesity induced a leptin-Notch signaling axis in breast cancer.Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.
P2860
Q24564267-E508178D-9F61-431C-BB91-458F0AACA091Q26766395-954DE99E-C5CA-49F0-8364-2975980BEB83Q26798420-164AAC67-B736-488C-A4C6-D4057AB12981Q26859634-9A25561B-1FCC-4D96-840D-C31881DB7DDAQ26864372-2D91CC8A-4893-4233-B90D-F3E2BFBA89D3Q28478427-C41DE715-264B-4D75-AA97-39CA97655452Q28540634-AB424E85-834F-449C-9ED5-176D6B1E4660Q30396675-7D6A4AF6-3938-4BF2-8AA6-FE4CF89E903CQ33555227-65C72103-DA1E-48DB-8D72-60ADA3636792Q33688508-B103084C-C01E-44B8-A145-8D3F97C43AAFQ33732419-E529B899-0E76-4A86-BA75-6ED700D125FEQ33758223-DDC7431C-5687-4232-A435-D22FC423071EQ33776761-9CAABC8C-B179-46D3-B3B1-ED8DA8DE5B94Q33914001-06DD1F91-49A4-4829-BC64-8B13C3BBE51CQ33948137-FEB919B4-F91C-4E2C-8FD4-616D957CBCC6Q34408556-FD40E106-AB38-4C8B-92EE-DF67D84C913CQ34664059-2F3E08A3-DE9B-49E0-BEA6-378895407D49Q34697373-30B30CCD-D16E-40B1-A90E-6DCFB4D86F1AQ35013660-9F44BC69-BE6A-4061-B748-7D2E39ADC8F5Q35134466-EC063203-2FF9-4CFE-9C9E-5516F1B498F4Q35159023-2E769059-AF52-499E-8599-D5F671F2F383Q35522043-74E82437-E6DE-4D63-AEFB-FEFF77D27EF9Q35603713-8178A84B-9984-47DA-BC55-F80F2DF43E5EQ35634693-1FAE93D2-5F2E-4065-B156-6090B00688EEQ35687072-0B9FD0D9-91C1-4D97-B779-C9886E35DEF6Q35999467-14233939-37DF-4D07-A99F-18E5FCDEC9F5Q36174910-A6A072C8-E20F-434F-8957-74B29ED0C600Q36202278-8914C687-724D-4014-B88E-DC30A24CA484Q36224427-1F66EEB4-D2BF-4E5F-88AA-882C80E99DD7Q36290246-61D1933F-D110-49A4-B47E-4CDEFC5CAE24Q36306149-68A5F614-E17C-4EF6-8F2D-78A350BD51F2Q36339899-1ACB48F8-BC3D-4398-9522-D91CFEB025F3Q36881446-02F5A98C-0F82-4600-A5ED-CA37C281BB8DQ36983730-9B95ECE5-F368-4A71-AE29-0AB30BAD13DFQ37156492-27B6D418-889C-4B2A-BB12-0DDD8550D5DEQ37393976-A0649CAC-D9D7-4E4E-9304-83A4015BDF93Q37584296-473E8457-8FB8-4293-82BE-846A248986DFQ37585313-A6B3F7B6-6E18-4CE4-B02F-C1320E65CCEBQ37625788-57F33733-541F-46EA-9BEF-8F807C3AFE86Q38024791-EC765784-FE5F-4DFA-A326-4942F04CD5CB
P2860
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
@ast
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
@en
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
@nl
type
label
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
@ast
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
@en
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
@nl
prefLabel
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
@ast
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
@en
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
@nl
P2093
P2860
P1476
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
@en
P2093
Dejuan Kong
Fazlul H Sarkar
Sanjeev Banerjee
Zhiwei Wang
P2860
P304
P356
10.1016/J.BBCAN.2010.06.001
P407
P577
2010-06-22T00:00:00Z